← FDA DRUG APPROVALS

FDA ANDA · ANDA073006

CINOXACIN

Sponsor: TEVA

APPLICATION
ANDA073006
TYPE
ANDA
ORIGINAL APPROVAL
1992-02-28
LATEST ACTION
1997-12-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CINOXACINDiscontinued
CINOXACIN 500MG · CAPSULE · ORAL

Approval history

1997-12-10Manufacturing (CMC) · Supplement 7AP
1997-06-18Manufacturing (CMC) · Supplement 6AP
1995-02-16Manufacturing (CMC) · Supplement 5AP
1994-09-06Manufacturing (CMC) · Supplement 4AP
1993-01-12Labeling · Supplement 3AP
1992-10-26Manufacturing (CMC) · Supplement 2AP
1992-04-17Manufacturing (CMC) · Supplement 1AP
1992-02-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →